| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
IQV
IQVIA Holdings
|
Feb 06, 2026 | BUY |
Strong Buy
+34.3% avg upside
38 analysts
|
$225.00
31.90% Upside
|
-4.9% |
|
PHR
Phreesia
|
Jun 25, 2025 | BUY |
Strong Buy
+82.2% avg upside
21 analysts
|
— | -68.2% |
|
HQY
Healthequity
|
Jun 05, 2025 | BUY |
Strong Buy
+33.4% avg upside
20 analysts
|
$125.00
44.73% Upside
|
-21.3% |
|
VEEV
Veeva Systems
|
Jun 04, 2025 | HOLD |
Buy
+54.2% avg upside
36 analysts
|
$274.00
76.86% Upside
|
-37.0% |
|
DOCS
Doximity
|
May 27, 2025 | HOLD |
Buy
+61.4% avg upside
27 analysts
|
$60.00
193.45% Upside
|
-65.4% |
|
OMCL
Omnicell
|
May 20, 2025 | HOLD |
Strong Buy
+36.0% avg upside
12 analysts
|
$34.00
11.70% Downside
|
+49.8% |
|
HCAT
Health Catalyst
|
May 20, 2025 | BUY |
Buy
+215.1% avg upside
15 analysts
|
$9.00
408.53% Upside
|
-69.8% |
|
EVH
Evolent Health
|
May 09, 2025 | BUY |
Strong Buy
+121.1% avg upside
19 analysts
|
$13.00
178.39% Upside
|
-53.8% |
|
PGNY
Progyny
|
May 08, 2025 | HOLD |
Strong Buy
+11.9% avg upside
14 analysts
|
— | +1.5% |
|
WAY
Waystar Holding Corp.
|
Feb 18, 2025 | BUY |
Strong Buy
+106.0% avg upside
29 analysts
|
$47.00
157.49% Upside
|
-37.8% |
|
CCSI
Consensus Cloud Solutions
|
Nov 20, 2024 | SELL |
Buy
-12.6% avg upside
6 analysts
|
$22.00
35.63% Downside
|
+14.7% |
|
DH
Definitive Healthcare Corp
|
Jul 31, 2024 | SELL |
Hold
+658.6% avg upside
19 analysts
|
$5.00
532.97% Upside
|
-0.0% |
|
MDRX
Veradigm
|
Nov 18, 2022 | SELL |
Buy
+207.0% avg upside
22 analysts
|
$20.00
316.66% Upside
|
+29.6% |
|
SIG
Signet Jewelers
|
May 31, 2017 | HOLD |
Buy
+4.2% avg upside
15 analysts
|
$60.00
30.71% Downside
|
-8.3% |
|
UA
Under Armour
|
Oct 01, 2013 | HOLD |
Buy
+370.6% avg upside
30 analysts
|
$77.00
1292.36% Upside
|
· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.